Kalen Biomedical, LLC Signs Distribution Agreement With Cosmo Bio Co., Ltd

Montgomery Village, MD – February 22, 2009 – Kalen Biomedical, LLC (www.kalenbiomed.com ), is pleased to announce a distribution agreement with Cosmo Bio Co., LTD in Tokyo.

Kalen Biomedical, LLC products are now available through Cosmo Bio Co. giving us the opportunity to provide companies in Japan with our premium quality human lipoproteins. “Japan is one of the leading countries in cardiovascular research and other life science fields. We’re honored to join Cosmo Bio in their long standing support of life science research.” said Kathy K. Foxx, President of Kalen Biomedical.

About Kalen Biomedical, LLC

Kalen Biomedical, LLC is a growing biotechnology company focused on the production of essential products for cardiovascular research. The company is located in Montgomery County, Maryland USA, in proximity to major medical institutes and biotechnology companies. Kalen Biomedical’s flagship lipoprotein product line is manufactured to exacting standards of quality using tested raw materials. The lipoprotein product line includes native human lipoproteins and oxidized and acetylated low density lipoproteins (LDL). Lipoprotein probes offer the convenience of fluorescence or biotin labeled LDL. All products are supported by Kalen’s expert research team and are backed by Kalen’s performance guarantee.

About Cosmo Bio Co., LTD

Cosmo Bio provides the most up-to-date products and technical information available from world class manufacturers, to laboratories, research institutes, life science education and testing organizations throughout Japan mainly and pacific area. We are proud that our ability to supply a vast array of products and information allows us to serve the needs of all of our customers. By making full use of our international network, coupled with the highest quality information, we support the life sciences community with a level of commitment and responsibility befitting a company that is trusted by its valued customers.

MORE ON THIS TOPIC